Over 100 members of the Global NASH/MASH Council (GNC) and the Global Liver Council (GLC), representing leading hepatology experts from more than 30 countries worldwide, attended the 11th bi-annual GNC/GLC meeting held during AASLD 2025 in Washington, D.C. The meeting commenced with opening remarks from Professor Zobair Younossi, Chair of the GNC/GLC, who highlighted the councils’ remarkable accomplishments and productivity over the past years, including more than 45 ongoing global collaborative projects.
This was followed by an insightful presentation from our active collaborators in Saudi Arabia, showcasing their impressive nationwide screening initiatives for MASLD and other liver diseases.
The scientific program featured distinguished lectures by Professors Emmanuel A. Tsochatzis, Laurent Castera, Vincent Wong, Naim Alkhouri, Manal Abdelmalek, Shira Zelber-Sagi, and Aleksander Krag, who shared the latest data on MASLD related to non-invasive tests (NITs), risk stratification algorithms, new therapeutic options, lifestyle interventions, and the evolving concept of the dynamic spectrum of steatotic liver disease (SLD).
The meeting was enriched by lively discussions and constructive debates addressing the most pressing issues in MASLD and SLD, fostering collaboration and knowledge exchange among global leaders.
As proud members of the GNC/GLC, we remain committed to advancing the field of hepatology, promoting patient-centered care, and supporting policy initiatives that raise global awareness of liver disease, particularly MASLD as a critical non-communicable liver disease. We look forward to continued productivity and impactful global collaboration in our shared mission to improve liver health worldwide.
